Marloes van der Leest
Overview
Explore the profile of Marloes van der Leest including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
16
Citations
662
Followers
0
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Klein Wolterink F, Ab Mumin N, Appelman L, Derks-Rekers M, Imhof-Tas M, Lardenoije S, et al.
Eur Radiol
. 2024 Jan;
34(8):5451-5460.
PMID: 38240805
Objectives: To assess the diagnostic performance of 3D automated breast ultrasound (3D-ABUS) in breast cancer screening in a clinical setting. Materials And Methods: All patients who had 3D-ABUS between January...
2.
Israel B, Immerzeel J, van der Leest M, Hannink G, Zamecnik P, Bomers J, et al.
BJU Int
. 2021 Aug;
129(4):480-490.
PMID: 34358388
Objective: To assess the outcomes of pre-biopsy magnetic resonance imaging (MRI) pathways, as a tool in biopsy-naïve men with suspicion of prostate cancer, in routine clinical practice. Secondary outcomes included...
3.
Draulans C, Pos F, Smeenk R, Kerkmeijer L, Vogel W, Nagarajah J, et al.
Pract Radiat Oncol
. 2021 May;
11(3):202-211.
PMID: 33941347
Purpose: To assess the intermodality and intertracer variability of gallium-68 (Ga)- or fluorine-18 (F)-labeled prostate-specific membrane antigen (PSMA) positron emission tomography (PET) and biparametric magnetic resonance imaging (bpMRI)-based gross tumor...
4.
van der Leest M, Israel B, Engels R, Barentsz J
Eur Urol
. 2019 Dec;
77(3):e58-e59.
PMID: 31818520
No abstract available.
5.
Israel B, van der Leest M, Sedelaar M, Padhani A, Zamecnik P, Barentsz J
Eur Urol
. 2019 Nov;
77(4):469-480.
PMID: 31767492
Background: There is large variability among radiologists in their detection of clinically significant (cs) prostate cancer (PCa) on multiparametric magnetic resonance imaging (mpMRI). Objective: To reduce the interpretation variability and...
6.
Wegelin O, Exterkate L, van der Leest M, Kelder J, Bosch J, Barentsz J, et al.
Eur Urol Oncol
. 2019 Sep;
2(6):617-624.
PMID: 31519516
Background: Three techniques of magnetic resonance imaging (MRI)-based targeted biopsy (TB) of the prostate exist. There is no superiority regarding diagnostic efficacy of prostate cancer (PCa) detection. Objective: To compare...
7.
Bulte J, Halilovic A, Burgers L, Diepenbroek C, de la Roij R, Mann R, et al.
Am J Clin Pathol
. 2019 Aug;
153(1):58-65.
PMID: 31415692
Objectives: Vacuum-assisted biopsy (VAB) of the breast seems unsuitable for rapid processing due to large size. We tested microwave-based acceleration. Methods: As a proof-of-principle study, 9-gauge VAB specimens were taken...
8.
Venderink W, van Luijtelaar A, van der Leest M, Barentsz J, Jenniskens S, Sedelaar M, et al.
BJU Int
. 2019 Jun;
124(5):775-784.
PMID: 31237388
Objective: To determine the proportion of men avoiding biopsy because of negative multiparametric magnetic resonance imaging (mpMRI) findings in a prostate MRI expert centre, and to assess the number of...
9.
van der Leest M, Israel B, Cornel E, Zamecnik P, Schoots I, van der Lelij H, et al.
Eur Urol
. 2019 Jun;
76(5):574-581.
PMID: 31167748
Background: To make magnetic resonance imaging (MRI) more accessible to men at risk of high-grade prostate cancer (PCa), there is a need for quicker, simpler, and less costly MRI protocols....
10.
Wegelin O, Exterkate L, van der Leest M, Kummer J, Vreuls W, de Bruin P, et al.
Eur Urol
. 2018 Dec;
75(4):582-590.
PMID: 30522912
Background: Guidelines advise multiparametric magnetic resonance imaging (mpMRI) before repeat biopsy in patients with negative systematic biopsy (SB) and a suspicion of prostate cancer (PCa), enabling MRI targeted biopsy (TB)....